Skip to main content
. 2025 Oct 13;15(10):1447. doi: 10.3390/biom15101447
HF Heart failure
CVD Cardiovascular disease
IHD Ischemic heart disease
LVEF Left ventricular ejection fraction
HFrpEF HF with reduced ejection fraction
HFpEF HF with preserved ejection fraction
AS Atherosclerosis
SCFAs Short-chain fatty acids
TMAO Trimethylamine N-oxide
BAs Bile acids
LPS Lipopolysaccharide
TMA Trimethylamine
FMOs Flavin-containing monooxygenases
TMAU Trimethylaminuria
HFD High-fat diet
IL Interleukin
NLRP3 Nucleotide-binding oligomerization domain-like receptor containing pyrin domain 3
SIRT3 Sirtuin 3
SOD2 Superoxide dismutase 2
mtROS Mitochondrial reactive oxygen species
ROS Reactive oxygen species
TXNIP Thioredoxin-interacting protein
TNF Tumor necrosis factor
FA Fatty acid
OXPHOS Oxidative phosphorylation
PLIN4 Perilipin 4
OMA1 Overlapping activity with m-AAA protease 1
OGDHL Oxoglutarate dehydrogenase L
BAT Brown adipose tissue
CP Creatine phosphate
ATP Adenosine triphosphate
Ca2+ Calcium ion
eNOS Endothelial nitric oxide synthase
NOX2 NADPH oxidase 2
PIEZO1 Piezo type mechanosensitive ion channel component 1
WD Western diet
ANP atrial natriuretic peptide
β-MHC β-myosin heavy chain
TGF Transforming growth factor
NF Nuclear factor
BNP Brain natriuretic peptide
LV Left ventricular
NO Nitric oxide
CHF Chronic heart failure
HTN Hypertension
ANG Angiotensin
MI Myocardial infarction
RCT Reverse cholesterol transport
ApoE−/− Apolipoprotein E knockout
CADs Coronary artery diseases
SGLT2 Sodium-glucose cotransporter-2
ACEIs Angiotensin-converting enzyme inhibitors
MD Mediterranean diet
MF Multistrain formula
DMB 3,3-dimethyl-1-butanol
FMC Fluoromethylcholine
IMC Iodomethylcholine
T2DM Type 2 diabetes mellitus
ASCVD Atherosclerotic cardiovascular disease
ARBs Angiotensin receptor blockers
ARNIs Angiotensin receptor–neprilysin inhibitors
BBR Berberine
RES Resveratrol
GYP Gypenosides
LBPs Lycium barbarum polysaccharides
PU Puerarin
PMFs Polymethoxyflavones